Orfotab

PRESENTATION:

Orfotab 0.8: Each film coated tablet contains Orforglipron 0.8 mg.

Orfotab 2.5: Each film coated tablet contains Orforglipron 2.5 mg.

Orfotab 5.5: Each film coated tablet contains Orforglipron 5.5 mg.

Orfotab 9: Each film coated tablet contains Orforglipron 9 mg.

Orfotab 14.5: Each film coated tablet contains Orforglipron 14.5 mg.

Orfotab 17.2: Each film coated tablet contains Orforglipron 17.2 mg.

 

INDICATION:

Orfotab (Orforglipron) is indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. It is also being developed for chronic weight management in adults with obesity or overweight with weight-related comorbidities.

PACKAGING: 

Orfotab 0.8: Each Box containing 3x 10 tablets in Alu-Alu blister pack. Orfotab 2.5: Each Box containing 3x 10 tablets in Alu-Alu blister pack.

Orfotab 5.5: Each Box containing 3x 10 tablets in Alu-Alu blister pack.

Orfotab 9: Each Box containing 3x 10 tablets in Alu-Alu blister pack.

Orfotab 14.5: Each Box containing 3x 10 tablets in Alu-Alu blister pack.

Orfotab 17.2: Each Box containing 3x 10 tablets in Alu-Alu blister pack.